Icon

Noxafil - (40mg/ml; oral suspension)

Posaconazole Schering
40mg/ml; oral suspension
Less Than $1000 mn
Less Than 5
Less Than 5
More Than 5
None
None None
Noxafil® injection, delayed-release tablets, and oral suspension are indicated for prophylaxis of invasive Aspergillus and Candida infections in patients who are at high risk of developing these infections due to being severely immunocompromised
Yes
****** *** *** ***** ** **** **** ** **** ******* ******* *** **, **** ; ******* *** **, **** ; ******* *** *, **** *** *** ************ *********. ****** *** ****** ** ** ****** ****, ********** *** ********* **** ****** ***** *** ***** ** ********* *** *** *****. ** ****** ****** ** ****** ********* ****** *** ****. ******* ****** **** ***** **** ** **** **** ******* *** *** ************ *********. ** ****** **** **** ****** ******* ** *** ****. * ******* ********** *** ** ******** **** ****** ** ****. ****** ***** **** ********* *** *********** ** ** *** ****** ** ******* * ****** ********* ********.
Noxafil Patent 1 Patent 2 Patent 3 Patent 4
****** ******* ******* ******* *******
****** ******* ******* ******* *******
Company FTF Status / 180 days exclusivity 30-Months stay Current Litigation Status Current Approval Status Likelihood of launch
****** *** \ ** *** *, **** ******* **** ****** ***** ****
****** ** \ ** *** *, **** ******* **** ****** ***** ****
  1. ***** **, **** : ****** ******** ******** ***** *** **** ** ****** **** ******* *******, *******, *******.
  2. *** *, **** : ******** ***** * **** ******* ****** ** ******** ***** ** **.
  3. *** **, **** : ********* *** ******* **** ****** ***** *** ***** ** ********** *** *** *****.
  4. *** *, **** : ******** ***** * **** ******* ****** ** ****** ***** **** ** **** ******* *******, *******, *******.
  5. *** *, **** : ********** ********* **** ******

Download ParaIV Report


Download ParaIV Detailed Report


To get detailed report Contact Us

ParaIV Advanced Search






Please contact contact@researchdelta.com to get more details.